X
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
0
https://www.prnewswire.com/news-releases/mezzion-pharma-receives-clear-fda-path-forward-for-the-approval-of-udenafil-for-single-ventricle-heart-disease-301558085.html
https://www.prnewswire.com/news-releases/mezzion-announces-re-submission-of-new-drug-application-for-its-orphan-drug-udenafil-to-treat-patients-who-have-undergone-the-fontan-operation-for-single-ventricle-heart-disease-301257235.html
https://www.prnewswire.com/news-releases/mezzion-pharma-announces-that-it-has-conducted-a-type-c-meeting-with-the-fda-regarding-the-top-line-data-from-the-fuel-phase-3-clinical-trial-300936949.html
http://www.in-pharmatechnologist.com/Ingredients/Mezzion-hires-replacement-CMOs-and-says-Dr.-Reddy-s-hid-cGMP-problems
http://www.fiercepharma.com/manufacturing/mezzion-sues-dr-reddy-s-for-fraud-citing-plant-problems-cost-it-a-drug-approval
http://www.prnewswire.com/news-releases/mezzion-pharma-receives-special-protocol-assessment-spa-agreement-from-fda-for-udenafil-phase-3-studies-in-adolescents-with-single-ventricle-congenital-heart-disease-with-fontan-physiology-300240463.html
Market Place
Share 
